ACTRN12607000310460尚未招募不适用
In patients stabilised on mirtazapine therapy for depression, does the new orally disintegrating formulation rate more highly in terms of patient preference?
Adrenalin Strategics0 个研究点目标入组 1,600 人开始时间: 2007年6月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Routine presentation of patients treated with conventional oral tablet mirtazapine- opportunistic assessment of patient suitabiltiy for participation in survey- identified patient categories likely to prefer orally disintegrating tablet formulation- after conducting risk-benefit analysis, patients who are likely to have a positive benefit are offered the opportunity to participate- patients must be agreeable to trial of mirtazapine orally disintegrating tablet formulation.
排除标准
- •Patients not consenting to participation, or unable to provide valid consent- children aged < 18 years- depression not stabilised- duration of mirtazapine therapy < 3 months- known allergy or adverse effects to inactive ingredients in orally disintegrating formulation
研究者
相似试验
招募中
1 期
The effectiveness of mirtazapine in reducing dependence and the temptation to consume amphetamine and methamphetamine in patientsIRCT20230606058397N1Ahvaz University of Medical Sciences84
进行中（未招募）
不适用
Multicentre randomised double-blind, placebo-controlled 2x2 factorial trial investigating the effects of adding mirtazapine and folic acid to existing therapy for people with schizophrenia.MedDRA version: 14.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2009-014469-19-ITIVERSITY OF OXFORD334
尚未招募
Unknown
A comparative clinical experiment of mirtazapine and amitriptyline in India on patients with recurring symptoms of an upset stomach that have no obvious causeCTRI/2024/01/061596Indian Council of Medical Research (ICMR)
招募中
不适用
Effectiveness verification of Mirtazapine Patients with Acute AnxietyMental and behavioural disordersKCT0008183Chung-Ang Univerisity Hospital52
进行中（未招募）
1 期
A randomised placebo controlled trial in which mirtazapine, an antidepressant, is added for patients with depression in primary care who have not responded to treatment with first-line antidepressants.Treatment resistant depressionMedDRA version: 16.0Level: LLTClassification code 10045543Term: Unipolar depressionSystem Organ Class: 100000004873EUCTR2012-000090-23-GBniversity of Bristol470